|
|
Article: Tekmira Pharmaceuticals Corporation Announces Third Quarter 2009 Operating Results and Provides Corporate Update.(Financial report)
- Article from:
- Marketwire Canada
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VANCOUVER, BRITISH COLUMBIA, Nov 12, 2009 (Marketwire via COMTEX) -- Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today its operating results for the third quarter of 2009.
Dr. Mark J. Murray, Tekmira's President and CEO, said, "We made significant progress on all aspects of our business during the third quarter of 2009, including the advancement of our two lead product candidates. We continued to earn significant revenue from our pharmaceutical partners who are advancing products enabled by our leading RNAi delivery technology while we remain focused on ...